Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data

P Baliakas, M Iskas, A Gardiner, Z Davis, K Plevova, F Nguyen-Khac, J Malcikova, A Anagnostopoulos, S Glide, S Mould, K Stepanovska, M Brejcha, C Belessi, F Davi, S Pospisilova, A Athanasiadou, K Stamatopoulos, D Oscier

. 2014 ; 89 (3) : 249-255.

Jazyk angličtina Země Spojené státy americké

Perzistentní odkaz   https://www.medvik.cz/link/bmc19036349

Grantová podpora
NT13493 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje Online Plný text

NLK Free Medical Journals od 1998 do Před 1 rokem
Wiley Free Content od 1996 do Před 1 rokem

The significance of chromosomal translocations (CTRAs) and karyotype complexity (KC) in chronic lymphocytic leukemia (CLL) remains uncertain. To gain insight into these issues, we evaluated a series of 1001 CLL cases with reliable classic cytogenetic data obtained within 6 months from diagnosis before any treatment. Overall, 320 cases were found to carry >= 1 CTRAs. The most frequent chromosome breakpoints were 13q, followed by 14q, 18q, 17q, and 17p; notably, CTRAs involving chromosome 13q showed a wide spectrum of translocation partners. KC (>= 3 aberrations) was detected in 157 cases and significantly (P < 0.005) associated with unmutated IGHV genes and aberrations of chromosome 17p. Furthermore, it was identified as an independent prognostic factor for shorter time-to-first-treatment. CTRAs were assigned to two categories (i) CTRAs present in the context of KC, often with involvement of chromosome 17p aberrations, occurring mostly in CLL with unmutated IGHV genes; in such cases, we found that KC rather than the presence of CTRAs per se negatively impacts on survival; (ii) CTRAs in cases without KC, having limited if any impact on survival. On this evidence, we propose that all CTRAs in CLL are not equivalent but rather develop by different processes and are associated with distinct clonal behavior. Copyright © 2013 Wiley Periodicals, Inc.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19036349
003      
CZ-PrNML
005      
20191010084746.0
007      
ta
008      
191010s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ajh.23618 $2 doi
035    __
$a (PubMed)24166834
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Baliakas P $u Baliakas, Panagiotis. Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
245    10
$a Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data / $c P Baliakas, M Iskas, A Gardiner, Z Davis, K Plevova, F Nguyen-Khac, J Malcikova, A Anagnostopoulos, S Glide, S Mould, K Stepanovska, M Brejcha, C Belessi, F Davi, S Pospisilova, A Athanasiadou, K Stamatopoulos, D Oscier
520    9_
$a The significance of chromosomal translocations (CTRAs) and karyotype complexity (KC) in chronic lymphocytic leukemia (CLL) remains uncertain. To gain insight into these issues, we evaluated a series of 1001 CLL cases with reliable classic cytogenetic data obtained within 6 months from diagnosis before any treatment. Overall, 320 cases were found to carry >= 1 CTRAs. The most frequent chromosome breakpoints were 13q, followed by 14q, 18q, 17q, and 17p; notably, CTRAs involving chromosome 13q showed a wide spectrum of translocation partners. KC (>= 3 aberrations) was detected in 157 cases and significantly (P < 0.005) associated with unmutated IGHV genes and aberrations of chromosome 17p. Furthermore, it was identified as an independent prognostic factor for shorter time-to-first-treatment. CTRAs were assigned to two categories (i) CTRAs present in the context of KC, often with involvement of chromosome 17p aberrations, occurring mostly in CLL with unmutated IGHV genes; in such cases, we found that KC rather than the presence of CTRAs per se negatively impacts on survival; (ii) CTRAs in cases without KC, having limited if any impact on survival. On this evidence, we propose that all CTRAs in CLL are not equivalent but rather develop by different processes and are associated with distinct clonal behavior.<ovid:br/><ovid:br/> Copyright &#xa9; 2013 Wiley Periodicals, Inc.
590    __
$a bohemika - dle Pubmed
650    02
$a buněčné kultury $x metody $7 D018929
650    02
$a chromozomální aberace $7 D002869
650    02
$a body zlomu chromozomu $7 D056905
650    02
$a chromozomální delece $7 D002872
650    02
$a lidské chromozomy $x genetika $x ultrastruktura $7 D002877
650    02
$a ženské pohlaví $7 D005260
650    02
$a přestavba genů pro těžké řetězce B-lymfocytů $7 D015326
650    02
$a lidé $7 D006801
650    02
$a hybridizace in situ fluorescenční $7 D017404
650    02
$a interfáze $7 D007399
650    02
$a Kaplanův-Meierův odhad $7 D053208
650    12
$a Karyotype
650    02
$a karyotypizace $x metody $7 D007621
650    12
$a chronická lymfatická leukemie $x genetika $x patologie $7 D015451
650    02
$a mužské pohlaví $7 D008297
650    02
$a proporcionální rizikové modely $7 D016016
650    12
$a translokace genetická $7 D014178
650    02
$a nádorové buňky kultivované $7 D014407
700    1_
$a Iskas M
700    1_
$a Gardiner A
700    1_
$a Davis Z
700    1_
$a Plevová, Karla $7 xx0158852
700    1_
$a Nguyen-Khac F
700    1_
$a Malčíková, Jitka, $d 1979- $7 mub2011655946
700    1_
$a Anagnostopoulos A
700    1_
$a Glide S
700    1_
$a Mould S
700    1_
$a Stepanovska K
700    1_
$a Brejcha, Martin $7 xx0105595
700    1_
$a Belessi C
700    1_
$a Davi F
700    1_
$a Pospíšilová, Šárka, $d 1969- $7 xx0101843
700    1_
$a Athanasiadou A
700    1_
$a Stamatopoulos K
700    1_
$a Oscier D
773    0_
$t American Journal of Hematology $g Roč. 89, č. 3 (2014), s. 249-255 $p Am J Hematol $x 0361-8609 $w MED00000251
773    0_
$p Am J Hematol $g 89(3):249-55, 2014 Mar
910    __
$a ABA008 $b sig $y 4 $z 0
990    __
$a 20191010085205 $b ABA008
991    __
$a 20191010085205 $b ABA008
999    __
$a ok $b bmc $g 1453436 $s 1074909
BAS    __
$a 3
BMC    __
$a 2014 $b 89 $c 3 $d 249-255 $x MED00000251 $i 0361-8609 $m American journal of hematology
GRA    __
$a NT13493 $p MZ0
LZP    __
$a NLK 2019/lp

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...